Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Duodenal Insulin Aspart
NCT00353990Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of insulin aspart in diabetes mellitus (DM), sponsored by Aarhus University. Primary endpoint: Bioavailability of Insulin Aspart Infused in the Duodenum. Started Aug 2006; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00353990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353990.